The incremental number of QALYs associated with SGLT2i use was projected at 29,357, and widespread use of SGLT2is was projected to lead to an incremental healthcare cost of AU$0.3 billion, resulting in an ICER of AU$8878 per QALY gained
Its diabetes counterpart, Victoza, maintained coverage for type 2 diabetes
503B facilities offer a higher level of regulatory oversight, providing several benefits, including validated sterile processes, dedicated cleanroom environments, comprehensive environmental monitoring programs, and lot-specific release testing for potency, sterility, and endotoxins
GUT AND DIGESTIVE SUPPORT: Contains CoreBiome tributyrin, a clinically studied ingredient that promotes gut health by supporting short-chain fatty acid activity and digestive balance.
Site rotation: Move injection sites (abdomen, thighs, upper arms), keeping each at least 1 inch from the last to limit irritation [15]